Kathlene Miyauchi, NP
Nurse Practitioner · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kathlene Miyauchi’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G20290 · Cancelled
Licence status: Cancelled · since 1971 · University of Vermont College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$18,288
Medicare paid this office $18,288 for 61 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 26 | $7,085 | $148 |
| Return visit (30+ min) | 29 | $5,498 | $104 |
| Short return visit (20+ min) | 24 | $3,243 | $75 |
Who their Medicare patients are
61 Original Medicare patients in 2024. Average age 75 · Women 100% · Health risk score 1.41. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 67% · Cancer 52% · Diabetes 26% · Chronic kidney disease 20%.
The office billed $65,392, Medicare allowed $23,061 and paid $18,288; for 171 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 61 | 171 | 75 | 1.41 | $65,392 | $18,288 |
| 2023 | 52 | 57 | 77 | 1.58 | $17,052 | $4,058 |
| 2022 | 94 | 112 | 77 | 1.51 | $32,041 | $7,864 |
| 2021 | 54 | 60 | 76 | 1.42 | $18,006 | $4,457 |
| 2020 | 21 | 22 | 79 | 3.19 | $7,318 | $1,926 |
| 2018 | 44 | 47 | 78 | 2.70 | $16,854 | $3,797 |
| 2017 | 150 | 163 | 75 | 3.71 | $40,302 | $7,835 |
| 2016 | 87 | 88 | 75 | 3.17 | $22,590 | $4,845 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 21 | $1,588 | $72 |
| New patient visit (15+ min) | 27 | $1,417 | $52 |
2022: 2 services
| New patient visit (15+ min) | 56 | $3,339 | $60 |
| Short return visit (20+ min) | 29 | $2,118 | $71 |
2021: 2 services
| Short return visit (20+ min) | 18 | $1,303 | $72 |
| New patient visit (15+ min) | 19 | $1,175 | $62 |
2017: 7 services
| Return visit (30+ min) | 31 | $1,834 | $56 |
| New patient visit (30+ min) | 26 | $1,385 | $53 |
| Short return visit (20+ min) | 30 | $1,125 | $36 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,053 | $53 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $839 | $76 |
| New patient visit (15+ min) | 15 | $577 | $38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $505 | $30 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $984 | $55 |
| New patient visit (30+ min) | 15 | $807 | $54 |
| Return visit (30+ min) | 13 | $774 | $60 |
| Short return visit (20+ min) | 13 | $503 | $39 |
Drugs they prescribed that Part D paid
$363,200
Pharmacies billed $363,200 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 15% of their Part D prescriptions (30 of 197) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
170 generic and 27 brand-name prescriptions · $363,200 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lynparza | 11 | $179,136 | $16,285 |
| Dexamethasone Sodium Phosphate | 13 | $497 | $38 |
| Dexamethasone | 21 | $383 | $18 |
| Ondansetron | 27 | $136 | $5 |
| Oxycodone-Acetaminophen | 17 | $122 | $7 |
See all 7 drugs
| Lynparza | 11 | $179,136 | $16,285 |
| Dexamethasone Sodium Phosphate | 13 | $497 | $38 |
| Dexamethasone | 21 | $383 | $18 |
| Ondansetron | 27 | $136 | $5 |
| Oxycodone-Acetaminophen | 17 | $122 | $7 |
| Prochlorperazine Maleate | 21 | $103 | $5 |
| Lorazepam | 14 | $41 | $3 |
Year by year
| 2024 | 197 | 67 | 15% (30) | 14% | $363,200 |
| 2021 | 19 | 15 | None | None | $1,834 |
| 2020 | 11 | None | None | None | $1,352 |
| 2019 | 20 | 13 | None | 0% | $337 |
| 2018 | 19 | 17 | 63% (12) | 0% | $134 |
| 2017 | 41 | 21 | 44% (18) | 0% | $338 |
| 2016 | 24 | 16 | None | None | $552 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$120 in 2025
A payment is not proof that care is biased.
| Myriad Genetic Laboratories | Precisetumor | $120 | 1 payment
|
See the published payment
| Myriad Genetic Laboratories | Meals · 2025-04-29 | Precisetumor | $120 |
Professional record
- NPI
- 1790075653
- Licence
- CA 20290, NY 336147California G20290: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 3131 Alum Rock Ave, San Jose, CA, 95127
- NPI first listed
- 2011-04-12
- NPI last updated
- 2011-04-12
This is when the NPI record was last certified, not a medical board exam.